These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28253482)

  • 1. AAV-Nrf2 Promotes Protection and Recovery in Animal Models of Oxidative Stress.
    Liang KJ; Woodard KT; Weaver MA; Gaylor JP; Weiss ER; Samulski RJ
    Mol Ther; 2017 Mar; 25(3):765-779. PubMed ID: 28253482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Intravitreal AAV-Mediated Inner Retinal Gene Transduction after Surgical Internal Limiting Membrane Peeling in Cynomolgus Monkeys.
    Takahashi K; Igarashi T; Miyake K; Kobayashi M; Yaguchi C; Iijima O; Yamazaki Y; Katakai Y; Miyake N; Kameya S; Shimada T; Takahashi H; Okada T
    Mol Ther; 2017 Jan; 25(1):296-302. PubMed ID: 28129123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.
    Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA
    Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal Penetrating Adeno-Associated Virus.
    Kumar B; Mishra M; Cashman S; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2024 Aug; 65(10):30. PubMed ID: 39172462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide.
    Ildefonso CJ; Jaime H; Brown EE; Iwata RL; Ahmed CM; Massengill MT; Biswal MR; Boye SE; Hauswirth WW; Ash JD; Li Q; Lewin AS
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):372-86. PubMed ID: 26842755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mouse Model of Retinal Recovery From Photo-Oxidative/Photo-Inflammatory Injury: Nrf2, SOD1, DJ-1, and Parkin Are Not Essential to Recovery.
    Chen B; Aredo B; Zhu Y; Ding Y; Xin-Zhao C; Ufret-Vincenty RL
    Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):1165-1174. PubMed ID: 30908580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage.
    Xiong W; MacColl Garfinkel AE; Li Y; Benowitz LI; Cepko CL
    J Clin Invest; 2015 Apr; 125(4):1433-45. PubMed ID: 25798616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Antioxidant Gene Therapy: Implications for Treating Dry AMD.
    Biswal MR; Han P; Zhu P; Wang Z; Li H; Ildefonso CJ; Lewin AS
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1237-1245. PubMed ID: 28241311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.
    Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR
    Gene Ther; 2006 Sep; 13(18):1328-41. PubMed ID: 16708079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation.
    Ildefonso CJ; Jaime H; Rahman MM; Li Q; Boye SE; Hauswirth WW; Lucas AR; McFadden G; Lewin AS
    Hum Gene Ther; 2015 Jan; 26(1):59-68. PubMed ID: 25420215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17β-Estradiol up-regulates Nrf2 via PI3K/AKT and estrogen receptor signaling pathways to suppress light-induced degeneration in rat retina.
    Zhu C; Wang S; Wang B; Du F; Hu C; Li H; Feng Y; Zhu R; Mo M; Cao Y; Li A; Yu X
    Neuroscience; 2015 Sep; 304():328-39. PubMed ID: 26211446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress.
    Nagar S; Noveral SM; Trudler D; Lopez KM; McKercher SR; Han X; Yates JR; Piña-Crespo JC; Nakanishi N; Satoh T; Okamoto SI; Lipton SA
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4048-E4056. PubMed ID: 28461502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.
    Boye SE; Alexander JJ; Witherspoon CD; Boye SL; Peterson JJ; Clark ME; Sandefer KJ; Girkin CA; Hauswirth WW; Gamlin PD
    Hum Gene Ther; 2016 Aug; 27(8):580-97. PubMed ID: 27439313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.
    Scalabrino ML; Boye SL; Fransen KM; Noel JM; Dyka FM; Min SH; Ruan Q; De Leeuw CN; Simpson EM; Gregg RG; McCall MA; Peachey NS; Boye SE
    Hum Mol Genet; 2015 Nov; 24(21):6229-39. PubMed ID: 26310623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene.
    Palfi A; Millington-Ward S; Chadderton N; O'Reilly M; Goldmann T; Humphries MM; Li T; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
    Hum Gene Ther; 2010 Mar; 21(3):311-23. PubMed ID: 19824806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
    Schlichtenbrede FC; MacNeil A; Bainbridge JW; Tschernutter M; Thrasher AJ; Smith AJ; Ali RR
    Gene Ther; 2003 Mar; 10(6):523-7. PubMed ID: 12621456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro.
    Tanito M; Agbaga MP; Anderson RE
    Free Radic Biol Med; 2007 Jun; 42(12):1838-50. PubMed ID: 17512463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.